1. Residencies & Fellowships
Doctors group shot

Dermatology Residency at The Mount Sinai Hospital

The Dermatology Residency at The Mount Sinai Hospital provides trainees the opportunity to join our rigorous, cutting-edge Department of Dermatology, which serves tens of thousands of patients each year. Given the size of our patient population, our residents encounter a wide variety of cutaneous diseases and syndromes.

Our residents work directly with members of the faculty on a one-on-one basis and run their own clinics under the supervision of voluntary attendings. In addition, they see consultations at hospitals across the Mount Sinai Health System. Because of the nature of the Health System, residents obtain significant experience not only in common skin diseases but also in rare, complex conditions such as neurofibromatosis, cutaneous sarcoid, and other illnesses, for which Mount Sinai’s specialty clinics are famous.

We have combined the residency program at The Mount Sinai Hospital with the programs at Mount Sinai Morningside, Mount Sinai West, and Mount Sinai Beth Israel. All training takes place at these hospitals.

Our Department runs one of the busiest phototherapy units in the world, where we administer a wide array of treatments to patients with cutaneous conditions that respond to ultraviolet light treatment. Conditions we treat include psoriasis, cutaneous T-cell lymphoma, atopic dermatitis, and various pruritic disorders, and we serve about 50 patients a day.

We also have extensive experience using excimer laser for psoriasis, vitiligo, and a variety of other conditions. Our residents have the ability to study any or all of these procedures while working in the faculty practice.

Our Department also encompasses a Division of Dermatologic and Mohs Micrographic Surgery, where residents work with the director to acquire skills and knowledge about Mohs surgery and laser treatment. As part of the core curriculum, residents spend time assisting Mohs surgeons with various repairs and cosmetic procedures.

Residents perform a range of cosmetic procedures in our resident-run cosmetic clinics, which thrive under direct faculty supervision. Among the procedures performed are botulinum toxin injection, fillers for soft tissue augmentation, microdermabrasion, peels, sclerotherapy, skin grafts, hair transplantation, fat transfer, liposuction, lasers for pigmented and vascular lesions, and nonablative photo rejuvenation techniques.

Our residents enjoy the opportunity of working individually and in groups with several experienced dermatopathologists. Opportunities for learning extend from direct observation to conducting independent research projects under the supervision of the head of the Division of Dermatopathology. A dermatopathology course is part of the core curriculum, and each week, residents meet with the chief of the Division to review textbook material and analyze the results of biopsies performed in the clinic.

Our residents rotate through six main outpatient clinical sites that serve diverse populations in three boroughs. Our residents additionally see inpatient consults at four of our main hospitals (The Mount Sinai Hospital, Mount Sinai Beth Israel, Mount Sinai West, and Mount Sinai Morningside), rotate with our two Mohs surgeons, participate in our three resident surgical and cosmetic clinics, rotate with our dermatopathologists, and now staff our Teledermatology rotation.

Our residents participate in a well-rounded and diverse set of educational activities outside of the clinic. These include a weekly, resident-driven textbook review, weekly Grand Rounds, weekly faculty and resident lectures, dermatopathology lectures, and slide reviews. Additionally, our residents are encouraged to attend several symposia and conferences, including the American Academy of Dermatology, the Real World Dermatology for Residents, and several symposia hosted at the Icahn School of Medicine at Mount Sinai.

Our clinical trials in psoriasis have demonstrated that ultraviolet light can be blocked by many psoriasis treatments applied to the skin, and conversely, that some topical therapies are inactivated by ultraviolet light. Combinations of topical therapies that are incompatible have also been identified by the Department.

We have introduced several new topical and systemic treatments for psoriasis and for eczema, and we were the first to introduce topical immunomodulators for the treatment of precancerous lesions, known as actinic keratosis. We are now at the forefront of advancing newly identified treatments for alopecia areata and for vitiligo.

Our research staff is also studying 500 patients with pseudoxanthoma elasticum, a condition that is a model for accelerated aging characterized by prematurely aged skin, eye disease, and accelerated heart disease.

Applications for the program should be submitted through the Electronic Residency Application Service (ERAS). Please note that all appointments are made through the National Residency Match Program (NRMP). Applicants must register with both ERAS and NRMP to participate in each of the services.

Your application must include:

  • A current curriculum vitae with publications, presentations, and research activity included
  • A minimum of three letters of recommendation from faculty
  • Your medical school transcript (with graduation date)
  • Medical Student Performance Evaluation
  • Copy of Step 1 scores (While Step 2 CK is not a requirement, having it complete at the time of application is preferred) (No Failures)
  • A personal statement
  • Valid J1, H1 or Permanent Resident Visa required (if applicable); U.S. medical experience is required
  • Valid ECFMG Certificate (for applicants who graduated medical school outside the United States)
  • A preliminary/transitional year in an ACGME-accredited program is required before beginning the dermatology residency. Note: A pathology internship does not qualify.
  • Once completed, your ERAS application will be forwarded to our selection committee for review. Applicants with strong potential will be invited to interview the end of January.

Following the interview, both applicants and Mount Sinai will submit their rank order lists to ERAS.